Validation and implementation of drug-dependent antibody assays in clinical trials for safety monitoring of patients dosed with roxifiban, an orally bioavailable glycoprotein IIb/IIIa antagonist
Keywords: Immunogenicity; Drug-dependent antibody assay; Anti-drug antibody assay; Validation; Roxifiban; Differential ELISA